Metformin Triggers Autophagy to Attenuate Drug-Induced Apoptosis in NSCLC Cells, with Minor Effects on Tumors of Diabetic Patients
The biologic plausibility of an association between type 2 diabetes mellitus (T2D) and lung cancer has received increasing attention, but the results of investigations remain largely inconclusive. In the present study we investigated the influence of the anti-diabetic drug metformin on the cytotoxic...
Main Authors: | Zhiguang Xiao, Silvia Gaertner, Alicia Morresi-Hauf, Rebecca Genzel, Thomas Duell, Axel Ullrich, Pjotr G. Knyazev |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-05-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558617300489 |
Similar Items
-
EWSR1-fusion-negative, SMARCB1-deficient primary pulmonary myxoid sarcoma
by: Abbas Agaimy, et al.
Published: (2017-11-01) -
Repurposing loperamide to overcome gefitinib resistance by triggering apoptosis independent of autophagy induction in KRAS mutant NSCLC cells
by: Christy W.S. Tong, et al.
Published: (2020-01-01) -
Natural products targeting autophagy and apoptosis in NSCLC: a novel therapeutic strategy
by: Peiyi Qin, et al.
Published: (2024-04-01) -
Upregulation of endogenous TRAIL-elicited apoptosis is essential for metformin-mediated antitumor activity against TNBC and NSCLC
by: Shuang Liu, et al.
Published: (2021-06-01) -
Metformin attenuates inflammation and boosts autophagy in the liver and intestine of chronologically aged rats
by: Zheng Kuai, et al.
Published: (2023-12-01)